🔎 Trials Near Me

Pradžia › Limfoma › North Carolina › Durham

Limfoma klinikiniai tyrimai Durham, NC

17 tyrimai dėl Limfoma ieško dalyvių vietose Durham ir aplinkui (apytiksliai 30 mylių spinduliu). Atidarykite tyrimą, kad pamatytumėte, kas gali dalyvauti ir kaip susisiekti su tyrimo komanda.

Oficialus tyrimo tekstas (anglų kalba)

Ieškote dalyvių tyrimui? Pateikite jį šio puslapio viršuje – $99 už 30 dienų →

CD30 CAR for Relapsed/Refractory CD30+ T Cell Lymphoma

Renkami dalyviai2 fazė
  • Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill · už 10 mylių
Amžius nuo 18 iki 99 · Visoms lytims · Atnaujinta 2026-09-24 · NCT04083495

A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)

Renkami dalyviai2 fazė
  • Duke University, Durham
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-17 · NCT07221500

CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma

Renkami dalyviai1/2 fazė
  • Duke University Medical Center, Durham
12 Months – 21 Years · Visoms lytims · Atnaujinta 2026-09-11 · NCT04870944

Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML

Renkami dalyviai1/2 fazė
  • UNC School of Medicine, Division of Hematology, Chapel Hill · už 10 mylių
Amžius 12 ir vyresni · Visoms lytims · Atnaujinta 2026-09-03 · NCT04588922

DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology Clinics

Renkami dalyviai
  • Lineberger Comphrehensive Cancer Center at University of North Carolina, Chapel Hill · už 10 mylių
Amžius 60 ir vyresni · Visoms lytims · Atnaujinta 2026-08-14 · NCT06296368

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

Renkami dalyviai1/2 fazė
  • University of North Carolina at Chapel Hill/ University of North Carolina Medical Center, Chapel Hill · už 10 mylių
Amžius nuo 13 iki 90 · Visoms lytims · Atnaujinta 2026-08-06 · NCT06533579

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

Renkami dalyviai3 fazė
  • Duke Cancer Institute, Durham
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-04 · NCT07188558

DALY II USA/ MB-CART2019.1 for DLBCL

Renkami dalyviai2 fazė
  • Duke University Medical Center - Division of Hematologic Malignancies, Durham
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-07-13 · NCT04792489

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

Renkami dalyviai1 fazė
  • Duke University Medical Center, Durham
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-07-02 · NCT05131022

Combating Cancer-Related Fatigue: A Personalized Supportive Care Program

Renkami dalyviai
  • North Carolina Basnight Cancer Hospital, Chapel Hill · už 10 mylių
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-07-01 · NCT06860880

Registry of Older Patients With Cancer

Renkami dalyviaiStebimasis tyrimas
  • Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · už 10 mylių
Amžius 65 ir vyresni · Visoms lytims · Atnaujinta 2026-06-29 · NCT01137825

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

Renkami dalyviai1/2 fazė
  • Duke University Medical Center, Duke Cancer Center, Durham
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-04-16 · NCT03328078

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

Renkami dalyviai2 fazė
  • University of North Carolina, Chapel Hill · už 10 mylių
Amžius nuo 18 iki 66 · Visoms lytims · Atnaujinta 2026-03-17 · NCT06859424

Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Cancer Survivors

Renkami dalyviai
  • Duke Cancer Institute, Durham
Amžius nuo 18 iki 39 · Visoms lytims · Atnaujinta 2026-01-28 · NCT06371768

Study of Kappa Chimeric Antigen Receptor (CAR) T Lymphocytes Co-Expressing the Kappa and CD28 CARs for Relapsed/Refractory Kappa+ Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.

Renkami dalyviai1 fazė
  • Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill · už 10 mylių
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-01-20 · NCT04223765

Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer

Renkami dalyviaiStebimasis tyrimas
  • Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · už 10 mylių
Amžius nuo 18 iki 120 · Visoms lytims · Atnaujinta 2025-10-27 · NCT01137643

A Randomized Phase II Study Of Bruton Tyrosine Kinase Inhibitor With Or Without Venetoclax In Veterans With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

Renkami dalyviai2 fazė
  • Durham VA Medical Center, Durham, NC, Durham
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2025-10-14 · NCT06520098

Limfoma tyrimai kituose miestuose

Kiti tyrimai Durham

Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.